1-8 of 8
Jing Yuan Chooi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bivalent Histone Modifications By Reiibp Leads to Transcriptional Reprogramming and TLR7-BTK Driven IL-6 Pro-Inflammatory Response in t(4;14) Myelomagenesis

Phyllis SY Chong, Julia Lim, Jing Yuan Chooi, Wee-Joo Chng
Journal: Blood
Blood (2021) 138 (Supplement 1): 2202.
https://doi.org/10.1182/blood-2021-145839
Published: 2021
Journal Articles

NSD2 Regulates Pro-Metastatic Gene PTP4A3 through Chromatin Remodeling in Multiple Myeloma

Phyllis SY Chong, PhD, Jing Yuan Chooi, BSc, Julia Lim, Bsc, Wee-Joo Chng, MBBS, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28.
https://doi.org/10.1182/blood-2020-134766
Published: 2020
Journal Articles

NSD2 Interacts with SMARCA2 and Regulates Expression of Oncogenes CCND1 and PRL3 in T(4;14) Multiple Myeloma

Jing Yuan Chooi, BSc, Zhigang Xie, PhD, Jayantha Gunaratne, PhD, Dennis Keppei, PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4479.
https://doi.org/10.1182/blood-2018-99-110671
Published: 2018
Journal Articles

ASLAN003, a Novel and Potent Dihydroorotate Dehydrogenase (DHODH) Inhibitor, Induces Differentiation of Acute Myeloid Leukemia

Jianbiao Zhou, MD,PhD, Jessie Yiying Quah, B.S., Jing Yuan Chooi, BSc, Sabrina Hui-Min Toh, B.S., Yvonne Ng, B.S., Baohong Lin, B.S., Motomi Osato, MD, PhD, Qihui Seet, B.S., PhD, A.G. Lisa Ooi, B.S., PhD, Bertil Lindmark, MD PhD, Mark McHale, B.S., PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4047.
https://doi.org/10.1182/blood-2018-99-114392
Published: 2018
Journal Articles

CD55 and CD59 Can Limit the Anti-Tumor Efficacy of Daratumumab in Natural Killer/T-Cell Lymphoma

Nurulhuda Mustafa, PhD, Adina Huey Fang Nee, BSc, Jing Yuan Chooi, BSc, Sabrina Hui Min Toh, BSc, Yan Ting Hee, BSc, Viknesvaran Selvarajan, PhD, Longen Zhou, PhD, Jennifer Yang, PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 1663.
https://doi.org/10.1182/blood-2018-99-115566
Published: 2018
Journal Articles

Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis

Phaik Ju Teoh, Omer An, Tae-Hoon Chung, Jing Yuan Chooi, Sabrina H. M. Toh, Shuangyi Fan, Wilson Wang, Bryan T. H. Koh, Melissa J. Fullwood, Melissa G. Ooi, Sanjay de Mel, Cinnie Y. Soekojo, Leilei Chen, Siok Bian Ng, Henry Yang, Wee Joo Chng
Journal: Blood
Blood (2018) 132 (12): 1304–1317.
https://doi.org/10.1182/blood-2018-02-832576
Published: 2018
Includes: Supplemental data
Journal Articles

MMSET I Acts As an Oncoprotein and Regulates GLO1 Expression in T(4;14) Multiple Myeloma Cells

Zhigang Xie, PhD, Jing Yuan Chooi, BSc, Sabrina Hui Min Toh, Bachelor, Wee Joo Chng, MB ChB, MRCP, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 563.
https://doi.org/10.1182/blood.V130.Suppl_1.563.563
Published: 2017
Journal Articles

MMSET Regulates IRF4, a Transcription Factor Critical for the Survival of T(4;14) Myeloma Myeloma Cells, and Its Silence Potentiates the Effect of Antimyeloma Agents

Zhigang Xie, PhD, Chonglei Bi, B.S, Jing Yuan Chooi, B.S, Zit Liang Chan, B.S, Nurulhuda Mustafa, PhD, Wee Joo Chng, MD PhD
Journal: Blood
Blood (2014) 124 (21): 171.
https://doi.org/10.1182/blood.V124.21.171.171
Published: 2014